Literature DB >> 15070787

Counterfeit drugs.

Paul M Rudolf1, Ilisa B G Bernstein.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15070787     DOI： 10.1056/NEJMp038231

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  10 in total

1.  Lay down the law on fakes.

Authors: 
Journal:  Nat Med       Date:  2010-04       Impact factor: 53.440

Review 2.  Substandard/counterfeit antimicrobial drugs.

Authors:  Theodoros Kelesidis; Matthew E Falagas
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

3.  Caveat oncologist: clinical findings and consequences of distributing counterfeit erythropoietin in the United States.

Authors:  Zaina P Qureshi; Leann Norris; Oliver Sartor; June M McKoy; John Armstrong; Dennis W Raisch; Vishvas Garg; Dana Stafkey-Mailey; Charles Lee Bennett
Journal:  J Oncol Pract       Date:  2011-12-13       Impact factor: 3.840

4.  Estimating the Effect of Health Insurance on Personal Prescription Drug Importation.

Authors:  Andrew R Zullo; Chanelle J Howe; Omar Galárraga
Journal:  Med Care Res Rev       Date:  2016-08-03       Impact factor: 3.929

5.  Diarrhoea in a large prospective cohort of European travellers to resource-limited destinations.

Authors:  Raffaela Pitzurra; Robert Steffen; Alois Tschopp; Margot Mutsch
Journal:  BMC Infect Dis       Date:  2010-08-04       Impact factor: 3.090

6.  Perceptions and practices of pharmaceutical wholesalers surrounding counterfeit medicines in a developing country: a baseline survey.

Authors:  Mohiuddin H Khan; Manabu Akazawa; Eav Dararath; Heng B Kiet; Tey Sovannarith; Nam Nivanna; Naoko Yoshida; Kazuko Kimura
Journal:  BMC Health Serv Res       Date:  2011-11-11       Impact factor: 2.655

7.  Exploring Consumer and Patient Knowledge, Behavior, and Attitude Toward Medicinal and Lifestyle Products Purchased From the Internet: A Web-Based Survey.

Authors:  Sulaf Assi; Mohamed Haffar; David Osselton; Jordan Thomas
Journal:  JMIR Public Health Surveill       Date:  2016-07-18

Review 8.  Counterfeit phosphodiesterase type 5 inhibitors pose significant safety risks.

Authors:  G Jackson; S Arver; I Banks; V J Stecher
Journal:  Int J Clin Pract       Date:  2010-01-18       Impact factor: 2.503

9.  Drug reimportation practices in the United States.

Authors:  Monali J Bhosle; Rajesh Balkrishnan
Journal:  Ther Clin Risk Manag       Date:  2007-03       Impact factor: 2.423

10.  The global threat of counterfeit drugs: why industry and governments must communicate the dangers.

Authors:  Robert Cockburn; Paul N Newton; E Kyeremateng Agyarko; Dora Akunyili; Nicholas J White
Journal:  PLoS Med       Date:  2005-03-14       Impact factor: 11.069
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.